OS-2966
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


OS-2966
Target :
IntegrinRelated Pathways :
Cytoskeletal SignalingPurity :
0.9935Bioactivity :
OS-2966 is a humanised de-immunised monoclonal antibody that targets and inhibits the adhesion receptor subunit Integrin b1/ITGB1/CD29, and can be used for the treatment of malignant gliomas, glioblastomas, and astrocytomas.Shipping Conditions :
Cool packStorage Temperature :
-20°C

